ISoftStone preps NYSE flotation

DangDang plans to issue 17 million American depository shares (ADS) at between $11 and $13 each in its flotation.

IDG Technology Ventures, a corporate venturing unit of IDG, owns 21.4 million B shares (6.8%) in E-Commerce China DangDang ahead of its US flotation.

Kaiser Permanente Ventures-backed AcelRx Pharmaceuticals preps its $86.25m flotation.

After the 7% initial public offering (IPO) fees, Samsung-backed Inphi raises $75.9m, before a further one million shares can potentially be sold through an over-allotment process.

Ikaria expected to sell eight rather than 10 million shares at its Nasdaq flotation.

Mail.ru sold 32.9 million global depositary receipts at $27.70 each for a market capitalization of $5.7bn, and the share price closed at $36 on Friday.

Inphi said it would sell up to 7.82 million shares in its initial public offering (IPO), including 6.8 million of new shares, at between $10 and $12 each.

Pacific Biosciences prices 12.5 million common shares at $16 each compared to $15 to $17 it set ahead of its initial public offering, and has a market capitalization of $802m on the Nasdaq stock exchange.

Linde, which owns 17% of Ikaria as part of a $380m cash-and-stock sale in 2007 of its gaseous drug-maker, INO Therapeutics, will see its stake diluted to 13.2% after the IPO.